MOXIFLOXACIN KABI
Solution for infusion, 400mg/250ml
RxActive license
Active substance (INN)
moxifloxacin
Pharmaceutical form
Pharmaceutical formSolution for infusion
Strength400mg/250ml
PackagingUkupno 10 boca plastičnih sa po 250ml rastvora za infuziju u kartonskoj kutiji
ManufacturerFresenius Kabi Polska Sp. z o.o., Poland
Therapeutic groupAnti-infectives for systemic use (J01MA14)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateFebruary 23, 2026
Analogs in Montenegro
6Other medicines with the same active substance
Source: CInMED register